Thrivent Financial for Lutherans’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-41,231
| Closed | -$435K | – | 2567 |
|
|
2024
Q2 | $435K | Sell |
41,231
-1,632
| -4% | -$20.7K | ﹤0.01% | 2278 |
|
|
2024
Q1 | $593K | Sell |
42,863
-1,164
| -3% | -$18.2K | ﹤0.01% | 2163 |
|
|
2023
Q4 | $855K | Sell |
44,027
-1,675
| -4% | -$30.9K | ﹤0.01% | 1930 |
|
|
2023
Q3 | $969K | Sell |
45,702
-2,039
| -4% | -$53K | ﹤0.01% | 1764 |
|
|
2023
Q2 | $1.58M | Sell |
47,741
-1,235
| -3% | -$45.5K | ﹤0.01% | 1496 |
|
|
2023
Q1 | $1.93M | Sell |
48,976
-1,716
| -3% | -$71.3K | ﹤0.01% | 1318 |
|
|
2022
Q4 | $2.14M | Buy |
50,692
+8,502
| +20% | +$327K | 0.01% | 1218 |
|
|
2022
Q3 | $1.41M | Buy |
42,190
+29,018
| +220% | +$1.21M | ﹤0.01% | 1456 |
|
|
2022
Q2 | $570K | Buy |
13,172
+153
| +1% | +$7.02K | ﹤0.01% | 2029 |
|
|
2022
Q1 | $623K | Sell |
13,019
-118
| -0.9% | -$5.85K | ﹤0.01% | 2087 |
|
|
2021
Q4 | $667K | Buy |
13,137
+32
| +0.2% | +$1.42K | ﹤0.01% | 2075 |
|
|
2021
Q3 | $530K | Sell |
13,105
-179
| -1% | -$9.06K | ﹤0.01% | 2157 |
|
|
2021
Q2 | $753K | Sell |
13,284
-233
| -2% | -$13.3K | ﹤0.01% | 2003 |
|
|
2021
Q1 | $715K | Sell |
13,517
-12,342
| -48% | -$672K | ﹤0.01% | 2062 |
|
|
2020
Q4 | $1.41M | Buy |
25,859
+12,019
| +87% | +$632K | ﹤0.01% | 1532 |
|
|
2020
Q3 | $693K | Sell |
13,840
-497
| -3% | -$23.6K | ﹤0.01% | 1797 |
|
|
2020
Q2 | $548K | Sell |
14,337
-177
| -1% | -$5.69K | ﹤0.01% | 1866 |
|
|
2020
Q1 | $317K | Hold |
14,514
| – | – | ﹤0.01% | 1953 |
|
|
2019
Q4 | $595K | Buy |
14,514
+92
| +0.6% | +$3.75K | ﹤0.01% | 1801 |
|
|
2019
Q3 | $613K | Sell |
14,422
-213
| -1% | -$8.94K | ﹤0.01% | 1714 |
|
|
2019
Q2 | $722K | Buy |
14,635
+252
| +2% | +$12.8K | ﹤0.01% | 1605 |
|
|
2019
Q1 | $688K | Buy |
14,383
+287
| +2% | +$17.4K | ﹤0.01% | 1616 |
|
|
2018
Q4 | $865K | Buy |
14,096
+685
| +5% | +$46.2K | ﹤0.01% | 1248 |
|
|
2018
Q3 | $1.1M | Buy |
13,411
+740
| +6% | +$58.8K | ﹤0.01% | 1206 |
|
|
2018
Q2 | $991K | Buy |
12,671
+1,451
| +13% | +$112K | ﹤0.01% | 1259 |
|
|
2018
Q1 | $827K | Buy |
11,220
+472
| +4% | +$33.5K | ﹤0.01% | 1339 |
|
|
2017
Q4 | $733K | Sell |
10,748
-714
| -6% | -$46.2K | ﹤0.01% | 1434 |
|
|
2017
Q3 | $705K | Buy |
11,462
+1,462
| +15% | +$89.7K | ﹤0.01% | 1359 |
|
|
2017
Q2 | $628K | Buy |
10,000
+750
| +8% | +$42.7K | ﹤0.01% | 1386 |
|
|
2017
Q1 | $514K | Buy |
+9,250
| New | +$476K | ﹤0.01% | 1518 |
|
|
2014
Q2 | – | Sell |
-9,050
| Closed | -$750K | – | 1730 |
|
|
2014
Q1 | $750K | Buy |
+9,050
| New | +$795K | ﹤0.01% | 799 |
|
Other funds holding NUS
Thrivent Financial for Lutherans's NUS Position: Q3 2024 in Review
Thrivent Financial for Lutherans sold out of Nu Skin (NUS) in Q3 2024, closing a stake of 41,231 shares — an estimated $435K sold.
Thrivent Financial for Lutherans first reported a position in NUS in Q1 2014 and held it in 31 quarters. The position peaked at $2.14M in Q4 2022. 203 funds tracked by Wall St. Rank hold NUS as of Q3 2024.
- Thrivent Financial for Lutherans reported no remaining Nu Skin position as of Q3 2024 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 41,231 Nu Skin shares in Q3 2024, an estimated $435K.
- Thrivent Financial for Lutherans first reported a position in Nu Skin in Q1 2014 and held it in 31 quarters.
- Thrivent Financial for Lutherans's Nu Skin position peaked at $2.14M in Q4 2022.
- 203 funds tracked by Wall St. Rank held Nu Skin as of Q3 2024.
Based on Thrivent Financial for Lutherans's 13F filing for Q3 2024, filed 7 Nov 2024.